BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30770971)

  • 1. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
    Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Ma X; Zhang L; Huang D; Lyu J; Fang M; Hu J; Zang Y; Zhang D; Shao H; Ma L; Tian J; Dong D; Lou X
    J Magn Reson Imaging; 2019 Apr; 49(4):1113-1121. PubMed ID: 30408268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder.
    Luo X; Li H; Xia W; Quan C; ZhangBao J; Tan H; Wang N; Bao Y; Geng D; Li Y; Yang L
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38127076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
    Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
    Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
    PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
    Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
    BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
    Wang Y; Wu A; Chen X; Zhang L; Lin Y; Sun S; Cai W; Zhang B; Kang Z; Qiu W; Hu X; Lu Z
    BMC Neurol; 2014 Dec; 14():246. PubMed ID: 25526927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
    Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
    Front Immunol; 2022; 13():897959. PubMed ID: 35774780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
    Kim W; Shin HG; Lee H; Park D; Kang J; Nam Y; Lee J; Jang J
    Radiology; 2023 Apr; 307(1):e220941. PubMed ID: 36413128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI characteristics of neuromyelitis optica spectrum disorder: an international update.
    Kim HJ; Paul F; Lana-Peixoto MA; Tenembaum S; Asgari N; Palace J; Klawiter EC; Sato DK; de Seze J; Wuerfel J; Banwell BL; Villoslada P; Saiz A; Fujihara K; Kim SH;
    Neurology; 2015 Mar; 84(11):1165-73. PubMed ID: 25695963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
    Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
    Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.